J F Guest

Summary

Affiliation: CATALYST Health Economics Consultants
Country: UK

Publications

  1. ncbi Modelling the economic impact of managing a chronic anal fissure with a proprietary formulation of nitroglycerin (Rectogesic) compared to lateral internal sphincterotomy in the United Kingdom
    Angela Christie
    CATALYST Health Economics Consultants, 34b High Street, Northwood, Middlesex HA6 1BN, UK
    Int J Colorectal Dis 17:259-67. 2002
  2. ncbi Cost implications of post-surgical morbidity following blood transfusion in cancer patients undergoing elective colorectal resection: an evaluation in the US hospital setting
    Julian F Guest
    CATALYST Health Economics Consultants, Northwood, UK
    Curr Med Res Opin 21:447-55. 2005
  3. ncbi Relative cost-effectiveness of a skin protectant in managing venous leg ulcers in the UK
    J F Guest
    CATALYST Health Economics Consultants, Northwood, UK
    J Wound Care 21:389-94, 396-8. 2012
  4. ncbi Utility values for chronic myelogenous leukemia chronic phase health states from the general public in the United Kingdom
    Julian F Guest
    CATALYST Health Economics Consultants, Northwood, UK
    Leuk Lymphoma 53:928-33. 2012
  5. ncbi Cost effectiveness of cilostazol compared with naftidrofuryl and pentoxifylline in the treatment of intermittent claudication in the UK
    Julian F Guest
    CATALYST Health Economics Consultants, Northwood, Middlesex, UK
    Curr Med Res Opin 21:817-26. 2005
  6. ncbi Modelling the costs and consequences of treating paediatric faecal impaction in Australia
    Julian F Guest
    CATALYST Health Economics Consultants, Northwood, Middlesex, UK
    Curr Med Res Opin 22:107-19. 2006
  7. ncbi Palliative care treatment patterns and associated costs of healthcare resource use for specific advanced cancer patients in the UK
    J F Guest
    CATALYST Health Economics Consultants, Northwood, UK
    Eur J Cancer Care (Engl) 15:65-73. 2006
  8. ncbi Modelling the resource implications and budget impact of new reimbursement guidelines for the management of cow milk allergy in Finland
    Julian F Guest
    CATALYST Health Economics Consultants, Northwood, Middlesex, UK
    Curr Med Res Opin 24:1167-77. 2008
  9. ncbi Health economic impact of olopatadine compared to branded and generic sodium cromoglycate in the treatment of seasonal allergic conjunctivitis in the UK
    Julian F Guest
    CATALYST Health Economics Consultants, Northwood, UK
    Curr Med Res Opin 22:1777-85. 2006
  10. ncbi Clinical and economic impact of using macrogol 3350 plus electrolytes in an outpatient setting compared to enemas and suppositories and manual evacuation to treat paediatric faecal impaction based on actual clinical practice in England and Wales
    Julian F Guest
    CATALYST Health Economics Consultants, Northwood, Middlesex, UK
    Curr Med Res Opin 23:2213-25. 2007

Collaborators

Detail Information

Publications43

  1. ncbi Modelling the economic impact of managing a chronic anal fissure with a proprietary formulation of nitroglycerin (Rectogesic) compared to lateral internal sphincterotomy in the United Kingdom
    Angela Christie
    CATALYST Health Economics Consultants, 34b High Street, Northwood, Middlesex HA6 1BN, UK
    Int J Colorectal Dis 17:259-67. 2002
    ..Hence, GTN is potentially a cost-effective first-line treatment strategy for the management of a chronic anal fissure...
  2. ncbi Cost implications of post-surgical morbidity following blood transfusion in cancer patients undergoing elective colorectal resection: an evaluation in the US hospital setting
    Julian F Guest
    CATALYST Health Economics Consultants, Northwood, UK
    Curr Med Res Opin 21:447-55. 2005
    ..To estimate the cost implications of blood transfusions and related surgical site infections (SSIs) in cancer patients undergoing elective colorectal resection in the hospital setting in the United States (US)...
  3. ncbi Relative cost-effectiveness of a skin protectant in managing venous leg ulcers in the UK
    J F Guest
    CATALYST Health Economics Consultants, Northwood, UK
    J Wound Care 21:389-94, 396-8. 2012
    ....
  4. ncbi Utility values for chronic myelogenous leukemia chronic phase health states from the general public in the United Kingdom
    Julian F Guest
    CATALYST Health Economics Consultants, Northwood, UK
    Leuk Lymphoma 53:928-33. 2012
    ..001). This study demonstrated and quantified the impact that more robust treatment responses have on the health-related quality of life of patients with chronic phase CML...
  5. ncbi Cost effectiveness of cilostazol compared with naftidrofuryl and pentoxifylline in the treatment of intermittent claudication in the UK
    Julian F Guest
    CATALYST Health Economics Consultants, Northwood, Middlesex, UK
    Curr Med Res Opin 21:817-26. 2005
    ..To estimate the cost effectiveness of cilostazol (Pletal) compared to naftidrofuryl and pentoxifylline (Trental) in the treatment of intermittent claudication in the UK...
  6. ncbi Modelling the costs and consequences of treating paediatric faecal impaction in Australia
    Julian F Guest
    CATALYST Health Economics Consultants, Northwood, Middlesex, UK
    Curr Med Res Opin 22:107-19. 2006
    ....
  7. ncbi Palliative care treatment patterns and associated costs of healthcare resource use for specific advanced cancer patients in the UK
    J F Guest
    CATALYST Health Economics Consultants, Northwood, UK
    Eur J Cancer Care (Engl) 15:65-73. 2006
    ..This analysis provides data on palliative care resource use for a variety of cancers and could provide useful input when planning local healthcare strategies and building service commissioning models...
  8. ncbi Modelling the resource implications and budget impact of new reimbursement guidelines for the management of cow milk allergy in Finland
    Julian F Guest
    CATALYST Health Economics Consultants, Northwood, Middlesex, UK
    Curr Med Res Opin 24:1167-77. 2008
    ....
  9. ncbi Health economic impact of olopatadine compared to branded and generic sodium cromoglycate in the treatment of seasonal allergic conjunctivitis in the UK
    Julian F Guest
    CATALYST Health Economics Consultants, Northwood, UK
    Curr Med Res Opin 22:1777-85. 2006
    ..This study estimated the health economic impact of olopatadine (Opatanol) compared to branded cromoglycate (Opticrom) and generic sodium cromoglycate in the treatment of seasonal allergic conjunctivitis (SAC) in the UK...
  10. ncbi Clinical and economic impact of using macrogol 3350 plus electrolytes in an outpatient setting compared to enemas and suppositories and manual evacuation to treat paediatric faecal impaction based on actual clinical practice in England and Wales
    Julian F Guest
    CATALYST Health Economics Consultants, Northwood, Middlesex, UK
    Curr Med Res Opin 23:2213-25. 2007
    ....
  11. ncbi Cost-effectiveness of using continuous positive airway pressure in the treatment of severe obstructive sleep apnoea/hypopnoea syndrome in the UK
    J F Guest
    CATALYST Health Economics Consultants, 34b High Street, Northwood, Middlesex HA6 1BN, UK
    Thorax 63:860-5. 2008
    ....
  12. ncbi Cost-effectiveness of macrogol 4000 compared to lactulose in the treatment of chronic functional constipation in the UK
    Julian F Guest
    CATALYST Health Economics Consultants, Northwood, Middlesex, UK
    Curr Med Res Opin 24:1841-52. 2008
    ..To estimate the cost-effectiveness of macrogol 4000 compared to lactulose in the treatment of chronic functional constipation, from the perspective of the National Health Service (NHS) in the UK...
  13. ncbi Modelling the resource implications and budget impact of managing cow milk allergy in Australia
    J F Guest
    CATALYST Health Economics Consultants, Northwood, Middlesex, UK
    Curr Med Res Opin 25:339-49. 2009
    ..To estimate the resource implications and budget impact of current clinical practice for managing cow milk allergy (CMA) in Australia, from the perspective of the publicly funded healthcare system...
  14. ncbi Cost-effectiveness of pentostatin compared with cladribine in the management of hairy cell leukemia in the United Kingdom
    Julian F Guest
    CATALYST Health Economics Consultants, Northwood, Middlesex, United Kingdom Postgraduate Medical School, University of Surrey, Guildford, Surrey, United Kingdom
    Clin Ther 31:2398-415. 2009
    ..This article assesses the cost-effectiveness of pentostatin compared with cladribine in the management of hairy cell leukemia (HCL) in the United Kingdom...
  15. ncbi Modelling the resource implications of managing adults with Fabry disease in Norway favours home infusion
    Julian F Guest
    CATALYST Health Economics Consultants, Northwood, Middlesex, UK
    Eur J Clin Invest 40:1104-12. 2010
    ..The aim of this study was to estimate the resource implications and budget impact of managing adults with Fabry disease in Norway, from the perspective of the publicly funded healthcare system...
  16. ncbi Modelling the resource implications of managing adults with Fabry disease in Italy
    Julian F Guest
    CATALYST Health Economics Consultants, Northwood, Middlesex, UK
    Eur J Clin Invest 41:710-8. 2011
    ..This study estimated the resource implications and budget impact of managing adults with Fabry disease in Italy, from the perspective of the Servizio Sanitario Nazionale (SSN)...
  17. ncbi Modeling the cost-effectiveness of prothrombin complex concentrate compared with fresh frozen plasma in emergency warfarin reversal in the United kingdom
    Julian F Guest
    CATALYST Health Economics Consultants, Northwood, Middlesex, United Kingdom
    Clin Ther 32:2478-93. 2010
    ..Indications for its long-term use include recurrent venous thrombosis, prosthetic heart valves, stroke prevention in atrial fibrillation, valvular heart disease, and prosthetic heart valve replacement...
  18. ncbi Health economic impact of managing patients following a community-based diagnosis of malnutrition in the UK
    Julian F Guest
    CATALYST Health Economics Consultants, Northwood, Middlesex, UK
    Clin Nutr 30:422-9. 2011
    ..To examine the effect of malnutrition on clinical outcomes and healthcare resource use from initial diagnosis by a general practitioner (GP) in the UK...
  19. ncbi Costs and consequences of using pamidronate compared with zoledronic acid in the management of breast cancer patients in the UK
    Julian F Guest
    CATALYST Health Economics Consultants, Northwood, Middlesex, UK
    Curr Med Res Opin 21:805-15. 2005
    ..To estimate the costs and consequences of using pamidronate compared to zoledronic acid in the prophylactic management of skeletal morbidity among breast cancer patients in the UK...
  20. ncbi Cost effectiveness of using carboxymethylcellulose dressing compared with gauze in the management of exuding venous leg ulcers in Germany and the USA
    Julian F Guest
    CATALYST Health Economics Consultants, Northwood, Middlesex, UK
    Curr Med Res Opin 21:81-92. 2005
    ..To assess the cost effectiveness of using carboxymethylcellulose dressing (CMCD; Aquacel Hydrofiber) compared to gauze in the management of exuding venous leg ulcers in Germany and the USA...
  21. ncbi Modelling the cost implications of using carboxymethylcellulose dressing compared with gauze in the management of surgical wounds healing by secondary intention in the US and UK
    Julian F Guest
    CATALYST Health Economics Consultants, Northwood, Middlesex, UK
    Curr Med Res Opin 21:281-90. 2005
    ..To estimate the costs of using carboxymethyl cellulose dressing (CMCD; Aquacel* Hydrofiber) compared to gauze in managing surgical wounds healing by secondary intention in the US and UK...
  22. ncbi A comparison of the resources used in advanced cancer care between two different strong opioids: an analysis of naturalistic practice in the UK
    Julian F Guest
    CATALYST Health Economics Consultants, Northwood, Middx, UK
    Curr Med Res Opin 21:271-80. 2005
    ..To assess the resource implications of using strong opioids in patients with advanced cancer in the UK, based on naturalistic practice, in order to develop the evidence base supporting better management...
  23. ncbi Clinical and economic evidence supporting a transparent barrier film dressing in incontinence-associated dermatitis and peri-wound skin protection
    J F Guest
    Catalyst Health Economics Consultant, Northwood, UK
    J Wound Care 20:76, 78-84. 2011
    ....
  24. ncbi Cost-effectiveness of venlafaxine XL compared with diazepam in the treatment of generalised anxiety disorder in the United Kingdom
    J F Guest
    Wyeth Laboratories, Maidenhead, UK
    Eur J Health Econ 6:136-45. 2005
    ....
  25. ncbi Impacted cerumen: composition, production, epidemiology and management
    J F Guest
    CATALYST Health Economics Consultants, 34b High Street, Northwood, Middlesex HA6 1BN, UK
    QJM 97:477-88. 2004
    ..Physicians are supposed to follow the edicts and principles of evidence-based medicine and clinical governance. Currently, in patients with impacted cerumen, the lack of evidence makes this impossible...
  26. ncbi Modelling the relative cost-effectiveness of amelogenin in non-healing venous leg ulcers
    J F Guest
    CATALYST Health Economics Consultants, Northwood, UK
    J Wound Care 18:216, 218-24. 2009
    ....
  27. ncbi The cost-effectiveness of macrogol 3350 compared to lactulose in the treatment of adults suffering from chronic constipation in the UK
    R R Taylor
    CATALYST Health Economics Consultants, Northwood, Middlesex, UK
    Aliment Pharmacol Ther 31:302-12. 2010
    ..It is unknown whether macrogol 3350 (Movicol) affords the UK's National Health Service (NHS) a cost-effective addition to the current range of laxatives...
  28. ncbi Resource implications and budget impact of managing cow milk allergy in the UK
    E Sladkevicius
    CATALYST Health Economics Consultants, 34b High Street, Northwood, Middlesex, UK
    J Med Econ 13:119-28. 2010
    ..To determine current treatment patterns for infants with cow milk allergy (CMA) and the associated resource implications and budget impact, from the perspective of the UK's National Health Service (NHS)...
  29. ncbi Economic impact of low dose polyethylene glycol 3350 plus electrolytes compared with lactulose in the management of idiopathic constipation in the UK
    Angela H Christie
    CATALYST Health Economics Consultants, Northwood, Middlesex, United Kingdom
    Pharmacoeconomics 20:49-60. 2002
    ..This suggests that the decision to use either PEG+E or lactulose to treat idiopathic constipation should be based on efficacy, safety, patient preferences and total management costs, and not drug acquisition costs...
  30. ncbi Modelling the cost-effectiveness of electric stimulation therapy in non-healing venous leg ulcers
    R R Taylor
    CATALYST Health Economics Consultants, Northwood, UK
    J Wound Care 20:464, 466, 468-72. 2011
    ....
  31. ncbi Cost analysis of palliative care for terminally ill cancer patients in the UK after switching from weak to strong opioids. Palliative Care Advisory Committee
    J F Guest
    CATALYST Health Economics Consultants, Pinner, Middlesex, England
    Pharmacoeconomics 14:285-97. 1998
    ....
  32. ncbi The annual cost of blood transfusions in the UK
    S J Varney
    CATALYST Health Economics Consultants, Northwood, Middlesex, UK
    Transfus Med 13:205-18. 2003
    ....
  33. ncbi Modelling the cost-utility of bio-electric stimulation therapy compared to standard care in the treatment of elderly patients with chronic non-healing wounds in the UK
    John P Clegg
    CATALYST Health Economics Consultants, Northwood, Middlesex, UK
    Curr Med Res Opin 23:871-83. 2007
    ....
  34. ncbi Economic impact of feeding a phenylalanine-restricted diet to adults with previously untreated phenylketonuria
    M C Brown
    CATALYST Health Economics Consultants, Pinner, Middlesex, UK
    J Intellect Disabil Res 43:30-7. 1999
    ..In conclusion, feeding a PHE-restricted diet to adults with previously untreated PKU leads to economic benefits to the UK's National Health Service and society in general...
  35. ncbi Annual cost of bipolar disorder to UK society
    Roben Das Gupta
    CATALYST Health Economics Consultants, Northwood, Middlesex, UK
    Br J Psychiatry 180:227-33. 2002
    ..Ten per cent of this cost is attributable to NHS resource use, 4% to non-health-care resource use and 86% to indirect costs...
  36. ncbi Relative cost effectiveness of Depo-Provera, Implanon, and Mirena in reversible long-term hormonal contraception in the UK
    Susan J Varney
    CATALYST Health Economics Consultants, Northwood, Middlesex, UK
    Pharmacoeconomics 22:1141-51. 2004
    ..Only by offering choice will the maximum number of women be protected and therefore the greatest savings to the health service be gained...
  37. ncbi Costs and outcomes over 36 years of patients with phenylketonuria who do and do not remain on a phenylalanine-restricted diet
    J F Guest
    CATALYST Health Economics Consultants, Northwood, UK School of Biomedical Sciences, King s College, London, UK Charles Dent Metabolic Unit, National Hospital for Neurology and Neurosurgery, London, UK
    J Intellect Disabil Res 57:567-79. 2013
    ..Nevertheless, patients require counselling and managed follow up regardless of the choices they make about their diet...
  38. ncbi Cost-utility of levonorgestrel intrauterine system compared with hysterectomy and second generation endometrial ablative techniques in managing patients with menorrhagia in the UK
    John P Clegg
    CATALYST Health Economics Consultants, Northwood, Middlesex, UK
    Curr Med Res Opin 23:1637-48. 2007
    ..e. microwave endometrial ablation (MEA) and thermal balloon endometrial ablation (TBEA)) and hysterectomy in the UK...
  39. ncbi The annual cost of dry eye syndrome in France, Germany, Italy, Spain, Sweden and the United Kingdom among patients managed by ophthalmologists
    John P Clegg
    CATALYST Health Economics Consultants, Northwood, Middlesex, UK
    Ophthalmic Epidemiol 13:263-74. 2006
    ....
  40. ncbi Costs and consequences of botulinum toxin type A use. Management of children with cerebral palsy in Germany
    Francis J Ruiz
    CATALYST Health Economics Consultants, Northwood, Middlesex, UK
    Eur J Health Econ 5:227-35. 2004
    ..However, it is unknown how botulinum toxin affected the need for surgery and associated outcomes in subsequent years...
  41. ncbi A model to estimate the cost benefit of an occupational vaccination programme for influenza with Influvac in the UK
    Roben Das Gupta
    CATALYST Health Economics Consultants, 34b High Street, Northwood, Middlesex HA6 1BN, United Kingdom
    Pharmacoeconomics 20:475-84. 2002
    ..Even if the incidence of influenza was as low as 2% it may be a worthwhile investment for UK employers to vaccinate their employees with Influvac...
  42. ncbi Factors affecting UK primary-care costs of managing patients with asthma over 5 years
    Roben Dasgupta
    CATALYST Health Economics Consultants, Northwood, Middlesex, UK
    Pharmacoeconomics 21:357-69. 2003
    ..Notwithstanding this, increasing compliance is likely to increase primary-care costs. Consequently increasing healthcare expenditure may be the inevitable consequence of improving asthma control...
  43. ncbi Health-related quality of life in a UK-based population of men with erectile dysfunction
    Julian F Guest
    CATALYST Health Economics Consultants, Northwood, Middlesex, England
    Pharmacoeconomics 20:109-17. 2002
    ..To measure health-related quality of life (HR-QOL) among a sample of men with erectile dysfunction (ED) in the UK...